Going on the offensive against one of the most daunting challenges in cancer, The Leukemia & Lymphoma Society (LLS) today announced the launch of a groundbreaking, collaborative clinical trial for acute myeloid leukemia (AML), a deadly disease which has seen few improvements in treatments in more than 40 years.
Beat AML was announced yesterday by Vice President Biden, along with many new, Moonshot inspired initiatives across industry, non-profit and government.
AML is the most lethal of the blood cancers, which together are the third leading cause of cancer deaths in the U.S.; AML is responsible for more than 10,000 deaths each year. Despite advances in treating other blood cancers, the standard of treatment for AML – a combination of toxic chemotherapies – has remained the same for more than 40 years. Overall prognosis remains poor, with a five-year survival rate below 20 percent for patients over age 60.
To view the multimedia release go to:
http://www.multivu.com/players/English/7554854-lls-beat-aml-acute-myeloid-leukemia/
Colgate announces a new addition to the Colgate Total® portfolio: Colgate Total® Clean-In-Between toothpaste. Building on the superior cleaning benefits of Colgate Total that consumers have come to expect, Clean-In-Between toothpaste’s advanced micro-foaming formula reaches even deep in between teeth to reduce 83 percent more plaque germs than non-antibacterial fluoride toothpaste 12 hours after brushing for healthier gums*.
Hispanics are one of the demographic populations with the poorest oral health of any racial and ethnic groups in the United States1. In spite of brushing twice a day, plaque can build up between teeth, which affects overall gum health. Colgate Total Clean-In-Between toothpaste provides 12-hour antibacterial protection for 100% of the mouth’s surfaces: teeth, tongue, cheeks and gums.
To view the multimedia release go to:
https://www.multivu.com/players/English/8103451-colgate-total-simplemente-saludable-initiative/
The science of bionics helped the more than 1 million Americans with leg amputations take a giant step forward, as the Rehabilitation Institute of Chicago (RIC) revealed clinical applications for the world’s first thought-controlled bionic leg in this week’s New England Journal of Medicine. This innovative technology represents a significant milestone in the rapidly-growing field of bionics. Until now, only thought-controlled bionic arms were available to amputees.
To view Multimedia News Release, go to http://www.multivu.com/mnr/63339-rehabilitation-institute-of-chicago-first-thought-controlled-bionic-leg
Heart disease affects all of us, either directly or indirectly. It is the leading cause of death in the United States. In an effort to make a positive difference in women's heart health, Progresso Heart Healthy soup is launching
The U.S. Food and Drug Administration (FDA) is alerting pregnant women about the risks of listeriosis, a foodborne disease that can severely affect a pregnant women and her unborn child.
Listeria can affect all races and ethnic groups, but pregnant women are 10 times more likely than other healthy adults to get listeriosis due to hormonal changes that affect the immune system during pregnancy. Pregnant Hispanic women are about 24 times more likely than the general population to get listeriosis. A pregnant mother may pass Listeria onto her unborn baby without even knowing it because she doesn’t feel sick at all, yet the disease can lead to miscarriage, stillbirth, premature labor, the delivery of a low birthweight infant, a wide range of health problems for a newborn, or even infant death.
To view the multimedia release go to:
https://www.multivu.com/players/English/7953451-fda-listeriosis-prevention-pregnant-women/
Results from the global Diabetes Attitudes, Wishes and Needs 2 study (DAWN2™) presented today at a symposium during the World Diabetes Congress of the International Diabetes Federation (IDF), show that only 29% of people with diabetes report that their healthcare team ask for their input when making their treatment plans. Furthermore, only 33% said they were encouraged by their healthcare professional to ask questions in the consultation.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64152-novo-nordisk-diabetes-report-doctor-treatment
DePuy Synthes Companies today announced the launch of Hit Play, an educational initiative that encourages those dealing with hip or knee pain to stop settling for a life on ‘pause’ and instead take action to get back to the activities and people they love most.
Osteoarthritis is one of the most common reasons for severe hip or knee pain, affecting nearly 27 million Americans today and will potentially affect up to 67 million people by 2030.1,2 In turn, demand for hip and knee replacements are expected to dramatically increase, yet many women see joint replacement as a “last resort” and often wait until the pain has become unbearable before turning to surgery. Through a series of compelling and relatable content, DePuy Synthes seeks to inspire the millions of people stuck on ‘pause’ due to hip or knee pain to explore joint replacement with a doctor, as a potential viable solution when they Hit Play.
To view the multimedia release go to:
http://www.multivu.com/players/English/79644241-lysol-madison-square-bgca-expose-germs/
Need a healthy life without any health problems? Want to feel better, have more energy and perhaps even live longer? Then look no further than exercise and it is very hard to ignore the benefits of it.
Today, WebMD released Advanced Breast Cancer: Courage, Comfort and Care with Robin Roberts, a five-part video series developed in partnership with Roberts and her independent production company, Rock’n Robin Productions. The series dives into the daily coping strategies of women living with advanced breast cancer, plus the families and friends who provide encouragement and support, and includes insights from medical experts leading the charge to combat the disease.
Over 255,000 people in the United States will be diagnosed with invasive breast cancer this year, and over 41,000 will die, with metastatic breast cancer being the leading cause of those fatalities. Despite these staggering statistics, there are signs of hope. Treatments for metastatic breast cancer are improving, and they continue to help people with the disease live longer and healthier lives.
To view the multimedia release go to:
https://www.multivu.com/players/English/8154851-webmd-advanced-breast-cancer-robin-roberts/
This February, the American Academy of Pediatric Dentistry (AAPD) is celebrating National Children’s Dental Health Month by hosting the Tournament of Tooth Care, showcasing how parents and caregivers can help their kids fend off the Mouth Monsters –a.k.a. tooth decay. Parents and caregivers can tune in to the Mouth Madness to learn how to help little teeth take on the Mouth Monsters one big game at a time.
“Tooth decay in children is a major health epidemic for adolescents across the country,” said Dr. Robert Delarosa, AAPD President. “National Children’s Dental Health Month is a great time for parents to keep their children’s dental health top of mind. Make it a priority this month to find a Dental Home – or home base – for your child’s oral health needs and be sure your next check-up is on the calendar.”
Tooth decay is one of the top chronic infectious diseases among children in the U.S. About 60 percent of children will have had tooth decay at some point by age five. More than 50 million school hours are missed every year by school-aged children in the U.S. due to dental visits or problems. And tooth decay isn’t just bad for oral health; children who develop tooth decay at a young age are at a greater risk for developing problems with oral and general health, as well as with educational and social development.
To view the multimedia release go to:
http://www.multivu.com/players/English/7750251-aapd-mouth-madness-dental-health/
Following the unprecedented Gore REDUCE Clinical Study conclusion that closure of patent foramen ovale (PFO) can prevent recurrent ischemic strokes, W. L. Gore & Associates, Inc. (Gore) has received approval from the U.S. Food and Drug Administration (FDA) for an expanded indication for its GORE® CARDIOFORM Septal Occluder. The device, already approved for closure of atrial septal defects (ASDs) up to 17 mm, is now also approved for the closure of PFO to reduce the risk of recurrent ischemic stroke in certain patients.*
To view the multimedia release go to:
https://www.multivu.com/players/English/8301551-gore-cardioform-septal-occluder-fda-approval/
Cuba was witness once again to the largest annual international event celebrating the Habano culture. The festival has come to an end with the celebration of the Gala Evening that paid tribute to the Cohiba brand on its 50th Anniversary, with exclusive tastings of its new releases. The gala hosted 1,200 guests that enjoyed live performances by Cuban pianist and composer, Chucho Valdes; the Spanish flamenco singer, Estrella Morente; and the Uruguayan singer-songwriter Jorge Drexler.
This year the traditional humidor auction of seven collector items reached a total of 865.000€ that will be entirely donated to the Cuban Public Health System. This edition has been especially unique thanks to the auction of the first humidor (01/50) of the exclusive special series “Cohiba 50 Aniversario”, which raised 320.000 euros. This humidor is an authentic work of art and a unique collector's item, and heralds a true innovation in terms of traditional craftsmanship and technical design and development.
During the evening, the “Maestro de Maestros” was chosen in the XV International Habanosommelier Contest. The winner was Juan Jesús Machín from Cuba. Luis Manuel García Urrea (United Arab Emirates) and Pedro Tejeda (Cuba) were runners-up in second and third place respectively.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7779251-international-stars-xviii-habanos-festival/
